MTOR and Langerhans cell histiocytosis: However, regarding our treatment failure in this case, we consider that undetermined genetic mutations beyond BRAF V600E might be involved, such as the PI3K/AKT/mTOR pathway or CSF1R genes reported in LCH and ECD [27].